Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flublok Quadrivalent vs IIV4 in Adults ≥50 Years
NCT02285998Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Oct 2014
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Oct 2014; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02285998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285998.